Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 6, 2008, Pages 1165-1172

  Goebel, Ulrich ^a   Siepe, Matthias ^a   Mecklenburg, Anne ^a   Doenst, Torsten ^b   Beyersdorf, Friedhelm ^a   Loop, Torsten ^a   Schlensak, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Carbon monoxide; Cardiopulmonary bypass; Inflammation; Pulmonary perfusion

Indexed keywords

CARBON MONOXIDE; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD GAS ANALYSIS; CARBON MONOXIDE INHALATION; CARDIOPULMONARY BYPASS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; INHALATION; LUNG BLOOD FLOW; LUNG PERFUSION; NONHUMAN; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE; SWINE; TRANSCRIPTION INITIATION;

ADMINISTRATION, INHALATION; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARBON MONOXIDE; CARDIOPULMONARY BYPASS; CASPASE 3; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-10; INTERLEUKIN-6; LUNG; MODELS, ANIMAL; NF-KAPPA B; PERFUSION; PNEUMONIA; PROTEIN BINDING; RANDOM ALLOCATION; SWINE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56049101357     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.07.031     Document Type: Article

References (19)

1. Grover F.L. The Society of Thoracic Surgeons National Database: current status and future directions. Ann Thorac Surg 68 (1999) 367-373
2. Hall R.I., Smith M.S., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85 (1997) 766-782
3. Gao D., Grunwald G.K., Rumsfeld J.S., Mackenzie T., Grover F.L., Perlin J.B., McDonald G.O., and Shroyer A.L. Variation in mortality risk factors with time after coronary artery bypass graft operation. Ann Thorac Surg 75 (2003) 74-81
4. Schlensak C., Doenst T., Preusser S., Wunderlich M., Kleinschmidt M., and Beyersdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg 123 (2002) 1199-1205
5. Lavitrano M., Smolenski R.T., Musumeci A., Maccherini M., Slominska E., Di Florio E., Bracco A., Mancini A., Stassi G., Patti M., Giovannoni R., Froio A., Simeone F., Forni M., Bacci M.L., D'Alise G., Cozzi E., Otterbein L.E., Yacoub M.H., Bach F.H., and Calise F. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J 18 (2004) 1093-1095
6. Liu X.M., Chapman G.B., Peyton K.J., Schafer A.I., and Durante W. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55 (2002) 396-405
7. Zhang X., Shan P., Otterbein L.E., Alam J., Flavell R.A., Davis R.J., Choi A.M., and Lee P.J. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278 (2003) 1248-1258
8. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T., Otterbein S.L., Otterbein L.E., and Choi A.M. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278 (2003) 36993-36998
9. Asimakopoulos G. Systemic inflammation and cardiac surgery: an update. Perfusion 16 (2001) 353-360
10. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
11. Ashraf S., Tian Y., Cowan D., Nair U., Chatrath R., Saunders N.R., Watterson K.G., and Martin PG:. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 63 (1997) 68-73
12. Hazama S., Eishi K., Yamachika S., Noguchi M., Ariyoshi T., Takai H., Odate T., Matsukuma S., Onohara D., and Yanatori M. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Ann Thorac Cardiovasc Surg 10 (2004) 90-96
13. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao L.H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 (2000) 422-428
14. El Kebir D., Hubert B., Taha R., Troncy E., Wang T., Gauvin D., Gangal M., and Blaise G. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest 128 (2005) 2910-2917
15. Sievers H.H., Freund-Kaas C., Eleftheriadis S., Fischer T., Kuppe H., Kraatz E.G., and Bechtel J.F. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 74 (2002) 1167-1172
16. Reis M.D., Gommers D., Struijs A., Dekker R., Mekel J., Feelders R., Lachmann B., and Bogers A.J. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg 28 (2005) 889-895
17. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6 (1999) 1028-1042
18. Takeuchi A., Vesely A., Rucker J., Sommer L.Z., Tesler J., Lavine E., Slutsky A.S., Maleck W.H., Volgyesi G., Fedorko L., Iscoe S., and Fisher J.A. A simple "new" method to accelerate clearance of carbon monoxide. Am J Respir Crit Care Med 161 (2000) 1816-1819
19. Graham B.L., Mink J.T., and Cotton D.J. Effects of increasing carboxyhemoglobin on the single breath carbon monoxide diffusing capacity. Am J Respir Crit Care Med 165 (2002) 1504-1510